Company
Headquarters: Tokyo, Japan
Employees: 547
CEO: Mr. Hideumi Akizawa
¥34.44 Billion
JPY as of Jan. 1, 2024
US$244.6 Million
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $63.92 B |
| Cencora, Inc. | $43.41 B |
| Cardinal Health, Inc. | $26.02 B |
| Henry Schein, Inc. | $9.72 B |
| Sinopharm Group Co. Ltd | $8.04 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and neurovascular occlusion coils; and insulin pumps, X-ray angio systems, and magnetic resonance imaging equipment. The company was founded in 1973 and is headquartered in Tokyo, Japan.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
WIN-Partners Co. Ltd has the following listings and related stock indices.
Stock: JPX: 3183 wb_incandescent